CYTK.NASDAQCytokinetics INC

Form 4: Cytokinetics CEO Blum Exercises Options and Sells Shares

Sentiment:

SEC Form 4

📋All filings for Cytokinetics INC
🔒Login to Follow

Robert I. Blum, President and CEO of Cytokinetics, exercised stock options and sold shares on September 16, 2024.

Summary

  • Robert I. Blum, the President and CEO of Cytokinetics Inc., engaged in transactions involving the company's common stock on September 16, 2024.
  • Blum exercised non-qualified stock options to acquire 5,000 shares of common stock at a price of $6.67 per share.
  • Simultaneously, Blum sold 5,000 shares of common stock at a price of $55.99 per share.
  • Following these transactions, Blum directly owns 397,456 shares of Cytokinetics common stock.
  • Additionally, Blum indirectly owns 2,083 shares through The Bridget Blum 2003 Irrevocable Trust and 2,083 shares through The Brittany Blum 2003 Irrevocable Trust.
  • He also holds 79,727 non-qualified stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The exercise of options and sale of shares is a common practice.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives who receive stock options as part of their compensation. Investors often monitor these filings for insights into management's perspective on the company's stock.

Key Dates

DateDescription
03/23/2016Date the Non-Qualified Stock Option (Right to Buy) was granted.
02/23/2026Expiration date of the Non-Qualified Stock Option (Right to Buy).
09/16/2024Date of the stock option exercise and share sale.
09/17/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.